Clinical Trials Directory

Trials / Unknown

UnknownNCT04220736

Early Prediction of QFR in STEMI-Pharmaco-invasice

EARLY Microvascular Dysfunction Prediction Using Quantitative Flow Ratio in ST-segment Elevation MYOcardial Infarction Patients With Pharmaco-Invasive Strategy (EARLY-MYO-QFR PI)

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The study intends to provide important data on whether the noval method using quantitative flow ratio could predict microvascular dysfunction.

Detailed description

Microvascular dysfunction (MVD) is a serious complication of PCI, which happens frequently after STEMI and always correlates with a poor prognosis. However, precise and simplified assessment of MVD is difficult, especially in the acute phase of STEMI patients. Resent studies suggested that FFR could be overestimated when MVD exists. But whether the overestimated value of FFR caused by CMR defined MVO could reflect microcirculation function is still unclear. This study is a retrospective study using STEMI patients who underwent pharmaco-invasive strategy as the population. Contrast-enhanced CMR was performed 5 days after PCI as the reference standard.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTComputation of quantitative flow ratioComputation of QFR was performed offline, using AngioPlus system(Pluse medical imaging technology, Shanghai, China). In the first step, 2 diagnostic angiographic projections before PCI, at least 25° apart, were selected and 3D reconstruction of the interrogated vessel without its side branches was performed. Then, the software computed the QFR.

Timeline

Start date
2018-01-01
Primary completion
2020-07-01
Completion
2020-07-25
First posted
2020-01-07
Last updated
2020-04-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04220736. Inclusion in this directory is not an endorsement.